The Application Value of Spectral CT in the Accurate Staging of Gastric Cancer
NCT ID: NCT06977386
Last Updated: 2025-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
150 participants
INTERVENTIONAL
2025-06-01
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Application Value of Spectral CT in the Accurate Staging of Liver Cancer
NCT06977399
99mTc-H7ND SPECT/CT Imaging in NSCLC
NCT05999214
Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung Cancer
NCT05925738
Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms
NCT06078930
Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer
NCT05925751
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The application value of spectral CT in the accurate staging of gastric cancer
Prospectively collect medical images and clinical data related to gastric cancer using Philips Quark CT equipment, and evaluate the diagnostic accuracy and clinical application value in the accurate staging of gastric cancer.Patients diagnosed with gastric cancer in Yunnan Provincial Cancer Hospital from April 2025 to May 2026 were consecutively included, and after scanning with Philips Quark CT, the TNM stage of gastric cancer patients was assessed by two radiologists, and finally statistical analysis was performed.
To explore the value of spectral CT in the diagnosis and treatment of gastric cancer
CT scan of the abdomen outside of standard treatment options
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
To explore the value of spectral CT in the diagnosis and treatment of gastric cancer
CT scan of the abdomen outside of standard treatment options
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* (b) aged ≥ 18 years old;
* (c) have not received chemoradiotherapy or surgery.
Exclusion Criteria
* (b) The image quality does not meet the diagnostic criteria;
* (c)Those who cannot tolerate CT examination.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yunnan Cancer Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lianhua Ye
Role: STUDY_DIRECTOR
Ethics Committee of Yunnan Provincial Cancer Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yunnan Cancer Hospital
Kunming, Yunnan, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KYLX2025-102
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.